AMX0035 clinical trials

Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment

This study is testing a new medicine called AMX0035 for people with Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neurone Disease. We want to see if it's safe and can help slow down the disease over 48 weeks compared to a dummy medicine.